Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence

In 2014, the Food and Drug Administration approved a new human papillomavirus 9-valent vaccine (9vHPV), targeting nine HPV types: HPV types 6, 11, 16, and 18, which are also targeted by the quadrivalent HPV vaccine (qHPV), plus five additional high cancer risk HPV types (HPV types 31, 33, 45, 52, an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Epidemiol Infect
Autors principals: SIGNORELLI, C., ODONE, A., CIORBA, V., CELLA, P., AUDISIO, R. A., LOMBARDI, A., MARIANI, L., MENNINI, F. S., PECORELLI, S., REZZA, G., ZUCCOTTI, G.V., PERACINO, A.
Format: Artigo
Idioma:Inglês
Publicat: Cambridge University Press 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5974698/
https://ncbi.nlm.nih.gov/pubmed/28446260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268817000747
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars